Drug Chatter -- Tracking biopharma stock chatter

Profile for Lifevantage Corporation (LXRX)

« Back to company index

LXRX Chatter Timeline

Stock Ticker for LXRX

Most Active Tweeters for LXRX

UserTweets
@DrSManian 7
@Flashtrading 6
@MarketNotes17 6
@Datamonitor_KMS 5
@CFinancialNews 5

Recent Tweets for LXRX

IRAMarketReport @IRAMarketReport
Lexicon Pharmaceuticals $LXRX Earns Daily Coverage Optimism Rating of 0.13 https://t.co/fyLzfa38RA
September 23rd 2017, 5:09pm
chaffeybreeze @chaffeybreeze
Lexicon Pharmaceuticals $LXRX Earns Daily Coverage Optimism Rating of 0.13 https://t.co/FZ83H3uW2X
September 23rd 2017, 5:09pm
emq_news @emq_news
Lexicon Pharmaceuticals, Inc. $LXRX Stake Held by Ulys L.L.C. https://t.co/HAAfXqxDpw
September 23rd 2017, 12:09pm
TheMarketsDaily @TheMarketsDaily
XBiotech $XBIT versus Lexicon Pharmaceuticals $LXRX Head-To-Head Contrast https://t.co/ZubuBUFe9C
September 22nd 2017, 9:09pm
finboxio @finboxio
Insider Buy: Lonnel Coats (Insider) bought $376K worth of $LXRX. Yup... stock's trading @ nice discount… https://t.co/1aryJLDiYb
September 22nd 2017, 1:09pm
Datamonitor_KMS @Datamonitor_KMS
@odibro Thought you might be interested in checking out our discussion on $LXRX's sotagliflozin starts at (0:30) https://t.co/3w1CAdD80w
September 22nd 2017, 11:09am
Datamonitor_KMS @Datamonitor_KMS
@DrSManian Thought you might be interested in checking out our discussion on $LXRX's sotagliflozin starts at (0:30) https://t.co/3w1CAdD80w
September 22nd 2017, 11:09am
Datamonitor_KMS @Datamonitor_KMS
@StocksInMyBlood Thought you might be interested in checking out our discussion on $LXRX's sotagliflozin starts at… https://t.co/9tatI8SX7H
September 22nd 2017, 11:09am
Datamonitor_KMS @Datamonitor_KMS
@sheltonwillia1 Thought you might be interested in checking out our discussion of $LXRX (starts at 0:30) https://t.co/3w1CAdD80w
September 22nd 2017, 11:09am
finboxio @finboxio
While stock's at 66% of 52week high, Lexicon Pharmaceuticals, Inc. $LXRX valuation shows upside… https://t.co/Gean7rBOAT
September 22nd 2017, 7:09am
PalafoxPatricia @PalafoxPatricia
$LXRX with all the ingredients 4 a great trade/long term. It has a very bullish weekly chart, excellent news insiders buying. #readytogo
September 21st 2017, 3:09pm
tymorapro @tymorapro
$LXRX: Exc 1DyHIGH=12.74, hits:1, ch:+1.2%, 3phNewHi+, AtgPivH4, 15:3Accel+, tf:0111111, medFlt:43M, HiPctSht[36%:11d], DyVol:96T:0.2x:0.1x
September 21st 2017, 12:09pm
IRAMarketReport @IRAMarketReport
Lexicon Pharmaceuticals, Inc. $LXRX Insider Acquires $376,200.00 in Stock https://t.co/sAsP7d3Lio
September 21st 2017, 6:09am
chaffeybreeze @chaffeybreeze
Lexicon Pharmaceuticals, Inc. $LXRX Insider Acquires $376,200.00 in Stock https://t.co/aV93HSiYxY
September 21st 2017, 6:09am
emq_news @emq_news
Analysts Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Post Quarterly Sales of $33.98 Million https://t.co/FeIc4zajEz
September 21st 2017, 5:09am
TickerReport @TickerReport
Analysts Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Post Quarterly Sales of $33.98 Million https://t.co/YcUkuI7Mci
September 21st 2017, 5:09am
TickerReport @TickerReport
Analysts Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Post Quarterly Sales of $33.98 Million https://t.co/BAOjW968iJ
September 21st 2017, 5:09am
intercooleronli @intercooleronli
Analysts Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Post Quarterly Sales of $33.98 Million https://t.co/l2qW3dYLgy
September 21st 2017, 5:09am
CFinancialNews @CFinancialNews
Analysts Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Post Quarterly Sales of $33.98 Million https://t.co/LU8kvEwhCr
September 21st 2017, 5:09am
ZolmaxNews @ZolmaxNews
$LXRX - Lexicon Pharmaceuticals, Inc. #LXRX Earns Buy Rating from Needham & Company LLC https://t.co/p4J8Til4Cn
September 21st 2017, 1:09am
ZolmaxNews @ZolmaxNews
Lexicon Pharmaceuticals, Inc. $LXRX Earns Buy Rating from Needham & Company LLC https://t.co/7X34SiUbGT
September 21st 2017, 1:09am
ZolmaxNews @ZolmaxNews
Sam L. Barker Acquires 1,000 Shares of Lexicon Pharmaceuticals, Inc. $LXRX Stock https://t.co/CkwM7jmkrD
September 20th 2017, 6:09am
dakotafinancial @dakotafinancial
Lexicon Pharmaceuticals’ $LXRX “Buy” Rating Reiterated at Needham & Company LLC https://t.co/1BS4oyMudj
September 20th 2017, 6:09am
TranscriptDaily @TranscriptDaily
Lonnel Coats Acquires 30,000 Shares of Lexicon Pharmaceuticals, Inc. $LXRX Stock https://t.co/aCj0bhdQqW
September 20th 2017, 5:09am
biostockfan @biostockfan
RT @BioRunUp: $LXRX European Commission Approves XERMELO® For The Treatment Of Carcinoid Syndrome Diarrhea In Combination With Somatostatin…
September 19th 2017, 5:09pm
intercooleronli @intercooleronli
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.35 Per Share https://t.co/HfUa0uX35J
September 19th 2017, 4:09pm
WatchlistN @WatchlistN
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.35 Per Share https://t.co/uo6XgKuL6b
September 19th 2017, 4:09pm
CFinancialNews @CFinancialNews
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.35 Per Share https://t.co/Z4jpBGaNLe
September 19th 2017, 4:09pm
MaisaCorp @MaisaCorp
$LXRX Gets Regulatory OK on Xermelo for Carcinoid Syndrome Diarrhea in Europe
September 19th 2017, 3:09pm
TraderJill77 @TraderJill77
$LXRX - presents for Cantor on September 25th. I move ahead very cautiously. Somewhat concerned over AEs like acidosis.
September 19th 2017, 3:09pm
realmaciej @realmaciej
RT @odibro: $LXRX EC Approves XERMELO® For The Treatment Of Carcinoid Syndrome Diarrhea In Combo With Somatostatin Analog Therapy
September 19th 2017, 2:09pm
MarketNotes17 @MarketNotes17
RT @DrSManian: $LXRX look for a red green move and a big #squeeze Insider buys and now ++ EC approval for Carcinoid.
September 19th 2017, 2:09pm
MomoTrader007 @MomoTrader007
$LXRX what's going on with this lepricon stock ?
September 19th 2017, 1:09pm
TraderJill77 @TraderJill77
$LXRX - With surface DD it looks like the stock was unjustly punished, thus, its fall from grace. I took a small position to see.
September 19th 2017, 1:09pm
sheltonwillia1 @sheltonwillia1
$LXRX Out flat after commissions, expected more run from this news. #stocks #trading
September 19th 2017, 1:09pm
SwingTradeBot @SwingTradeBot
Recent $LXRX technical alerts: Lower Bollinger Band Walk plus 7 more alerts... https://t.co/NdZ3NUTw8E
September 19th 2017, 1:09pm
pharma_sector @pharma_sector
BRIEF-#Lexicon Pharmaceuticals gets European Commission's approval for Xermelo. Read more: https://t.co/juKpyYgDzg $LXRX
September 19th 2017, 1:09pm
biotech_sector @biotech_sector
BRIEF-#Lexicon Pharmaceuticals gets European Commission's approval for Xermelo. Read more: https://t.co/Pns7J0B5pe $LXRX
September 19th 2017, 1:09pm
StocksInMyBlood @StocksInMyBlood
$JNUG $LXRX both look ready to turn up
September 19th 2017, 1:09pm
TraderJill77 @TraderJill77
$LXRX - Just approved in Europe. This could bounce nicely in the next couple of days, but I have done almost zero research. Worth a look.
September 19th 2017, 1:09pm
DrSManian @DrSManian
$LXRX look for a red green move and a big #squeeze Insider buys and now ++ EC approval for Carcinoid.
September 19th 2017, 12:09pm
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Ipsen's Xermelo OK'd in Europe for carcinoid syndrome diarrhea; shares ahead 5% https://t.co/MQKgQR1w7L $IPSEY $LXRX
September 19th 2017, 12:09pm
MarketCurrents @MarketCurrents
Ipsen's Xermelo OK'd in Europe for carcinoid syndrome diarrhea; shares ahead 5% https://t.co/Z7Y7sdxXmX $IPSEY $LXRX
September 19th 2017, 12:09pm
odibro @odibro
$LXRX EC Approves XERMELO® For The Treatment Of Carcinoid Syndrome Diarrhea In Combo With Somatostatin Analog Therapy
September 19th 2017, 12:09pm
BioRunUp @BioRunUp
$LXRX European Commission Approves XERMELO® For The Treatment Of Carcinoid Syndrome Diarrhea In Combination With Somatostatin Analog Therapy
September 19th 2017, 12:09pm
WizAtWallSt @WizAtWallSt
Breaking: $LXRX European Commission Approves XERMELO for treatment of Carcinoid Syndrome Diarrhea
September 19th 2017, 12:09pm
MarketNotes17 @MarketNotes17
$LXRX Xermelo just app'd by Euro Comm for treatment of carcinoid syndrome diarrhea
September 19th 2017, 12:09pm
TheMarketsDaily @TheMarketsDaily
Lexicon Pharmaceuticals, Inc. $LXRX Director Sam L. Barker Purchases 1,000 Shares of Stock https://t.co/IfJ7sXslWW
September 19th 2017, 6:09am
WatchlistN @WatchlistN
Lexicon Pharmaceuticals, Inc. $LXRX Insider Lonnel Coats Acquires 30,000 Shares of Stock https://t.co/TxW1tmJflq
September 19th 2017, 4:09am
4thQuarterCap @4thQuarterCap
Added to $LXRX
September 18th 2017, 9:09pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.